Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1632 1648 1671
This examiner grants 66% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18452524 | CONFORMATIONAL EPITOPES IN RESPIRATORY SYNCYTIAL VIRUS G PROTEIN CENTRAL CONSERVED REGION | Non-Final OA | The Regents of the University of California |
| 18031294 | ADENO-ASSOCIATED VIRUS VIRIONS AND METHODS OF USE THEREOF | Non-Final OA | The Regents of the University of California |
| 18289622 | NON-VIRAL DNA VECTORS FOR VACCINE DELIVERY | Non-Final OA | Generation Bio Co. |
| 18411568 | Ferritin Proteins | Non-Final OA | SANOFI |
| 18260767 | IDENTIFICATION AND USES OF PEPTIDE SEQUENCES OF SARS-COV-2 T CELL AND B CELL EPITOPES | Non-Final OA | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY |
| 18314980 | RESPIRATORY SYNCYTIAL VIRUS VACCINE | Final Rejection | ModernaTX, Inc. |
| 17796401 | RESPIRATORY VIRUS IMMUNIZING COMPOSITIONS | Non-Final OA | ModernaTX, Inc. |
| 18558875 | SARS-COV-2 SUBUNIT VACCINE | Non-Final OA | LABORATORIOS HIPRA, S.A. |
| 18554935 | MODIFIED VIRUS-LIKE PARTICLES OF BACTERIOPHAGE AP205 | Non-Final OA | SAIBA AG |
| 18285576 | SARS-COV-2 POLYPEPTIDES AND USES THEREOF | Non-Final OA | IAMA FRANCE |
| 18549625 | LATERAL FLOW TEST METHODS | Non-Final OA | Stichting Wageningen Research |
| 18549058 | DETECTION OF INFECTIOUS AGENT BASED ON RECOMBINASE POLYMERASE AMPLIFICATION COMBINED WITH A MAGNETIC FIELD-ENHANCED AGGLUTINATION | Non-Final OA | HORIBA ABX SAS |
| 18458789 | DOWNSTREAM PROCESS FOR PURIFICATION OF VIRAL PROTEINS WITH HYDROPHOBIC MEMBRANE DOMAIN FOR USE IN VACCINE COMPOSITIONS | Non-Final OA | Novavax, Inc. |
| 18548080 | VACCINE COMPOSITION FOR PREVENTING SARS-COV-2 | Non-Final OA | EYEGENE INC. |
| 18271250 | METHODS AND COMPOSITIONS FOR MODULATING THE INTERACTION BETWEEN ADENO-ASSOCIATED VIRUS (AAV) AND THE AAV RECEPTOR (AAVR) FOR ALTERED BIO-DISTRIBUTION OF AAV | Non-Final OA | THE SCHEPENS EYE RESEARCH INSTITUTE, INC. |
| 18258501 | MODIFIED PARAPOXVIRUS HAVING INCREASED IMMUNOGENICITY | Non-Final OA | EBERHARD KARLS UNIVERSITAET TUEBINGEN MEDIZINISCHE FAKULTAET |
| 18029806 | METHODS OF DETECTING ANTI-AAV ANTIBODIES | Non-Final OA | Sangamo Therapeutics, Inc. |
| 17924193 | COMPOSITION OF NANOPARTICLES AS CARRIER FOR HPV-DERIVED IMMUNOGENIC FRAGMENTS | Non-Final OA | UNIVERSITAT HEIDELBERG |
| 17843445 | MULTIVALENT INFLUENZA VACCINES | Final Rejection | SANOFI PASTEUR INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy